Taro Pharmaceutical Industries (TARO) received a non-binding offer from its majority shareholder Sun Pharmaceutical to acquire shares, it doesn’t already own for $38 per share

According to Reuters, Avid Technology (AVID), a provider of video and audio editing software and equipment to filmmakers and recording studios, is exploring a potential

According to WSJ, Choice Hotels International (CHH) is seeking to buy Wyndham Hotels & Resorts (WH). Update(s): October 17, 2023: Choice Hotels International announced a

According to the 13D filing,  Concentra Biosciences offered to buy Atea Pharmaceuticals (AVIR) for $5.75 a share in cash. May 30, 2023: Atea Pharmaceuticals, Inc.

According to WSJ, Activist investor TCS Capital Management has built a stake in Yelp (YELP) and is calling on the service-recommendation site to explore options

GoHealth (GOCO), a health insurance marketplace and Medicare-focused digital health company, as noted in a recent 13D filing, has received a proposal for cash consideration

Light & Wonder (LNW) announced that it has submitted a proposal to the Board of Directors of SciPlay Corporation (SCPL) under which Light & Wonder

According to WSJ, Private-equity firms Francisco Partners and TPG (TPG)  are working together on a $5 billion-plus bid to acquire software company New Relic (NEWR).

According to 13D filing, Legion Partners pushes Clear Channel Outdoor (CCO) to evaluate a sale of the entire company.

According to Bloomberg, Several major drugmakers keen to expand in immunology have been studying the $23 billion company Argenx (ARGX) and have it at the

National Western Life Group, Inc. (NWLI) announced that the company is exploring strategic alternatives in order to maximize value for the company’s stockholders.

Premier Inc (PINC) announced its board was evaluating strategic alternatives and had established a special committee of independent directors for potential options, including a sale of